Header Logo

Connection

MARGARET SPITZ to Risk Factors

Back to Details
This is a "connection" page, showing publications MARGARET SPITZ has written about Risk Factors.
MARGARET SPITZ
Connection Strength
2.214
Risk Factors
  1. Rare Variants in Known Susceptibility Loci and Their Contribution to Risk of Lung Cancer. J Thorac Oncol. 2018 10; 13(10):1483-1495.
    View in: PubMed
    Score: 0.055
  2. Exposure to pro-tobacco messages and smoking status among Mexican origin youth. J Immigr Minor Health. 2014 Jun; 16(3):385-93.
    View in: PubMed
    Score: 0.042
  3. Multistage analysis of variants in the inflammation pathway and lung cancer risk in smokers. Cancer Epidemiol Biomarkers Prev. 2012 Jul; 21(7):1213-21.
    View in: PubMed
    Score: 0.036
  4. Cigarette experimentation in Mexican origin youth: psychosocial and genetic determinants. Cancer Epidemiol Biomarkers Prev. 2012 Jan; 21(1):228-38.
    View in: PubMed
    Score: 0.035
  5. Variants in inflammation genes are implicated in risk of lung cancer in never smokers exposed to second-hand smoke. Cancer Discov. 2011 Oct; 1(5):420-9.
    View in: PubMed
    Score: 0.034
  6. Reproductive and hormonal factors and lung cancer risk in the NIH-AARP Diet and Health Study cohort. Cancer Epidemiol Biomarkers Prev. 2011 May; 20(5):900-11.
    View in: PubMed
    Score: 0.033
  7. Nicotinic acetylcholine receptor region on chromosome 15q25 and lung cancer risk among African Americans: a case-control study. J Natl Cancer Inst. 2010 Aug 04; 102(15):1199-205.
    View in: PubMed
    Score: 0.032
  8. Re: Discriminatory accuracy from single-nucleotide polymorphisms in models to predict breast cancer risk. J Natl Cancer Inst. 2009 Dec 16; 101(24):1731-2; author reply 1732.
    View in: PubMed
    Score: 0.030
  9. The CHRNA5-A3 region on chromosome 15q24-25.1 is a risk factor both for nicotine dependence and for lung cancer. J Natl Cancer Inst. 2008 Nov 05; 100(21):1552-6.
    View in: PubMed
    Score: 0.028
  10. Correlates of susceptibility to smoking among Mexican origin youth residing in Houston, Texas: a cross-sectional analysis. BMC Public Health. 2008 Sep 26; 8:337.
    View in: PubMed
    Score: 0.028
  11. Development and validation of a lung cancer risk prediction model for African-Americans. Cancer Prev Res (Phila). 2008 Sep; 1(4):255-65.
    View in: PubMed
    Score: 0.028
  12. Aggregation of cancer among relatives of never-smoking lung cancer patients. Int J Cancer. 2007 Jul 01; 121(1):111-8.
    View in: PubMed
    Score: 0.026
  13. Interplay between mutagen sensitivity and epidemiological factors in modulatinglung cancer risk. Int J Cancer. 2007 Jun 15; 120(12):2687-95.
    View in: PubMed
    Score: 0.026
  14. Mutagen sensitivity: a genetic predisposition factor for cancer. Cancer Res. 2007 Apr 15; 67(8):3493-5.
    View in: PubMed
    Score: 0.025
  15. A modified host-cell reactivation assay to measure repair of alkylating DNA damage for assessing risk of lung adenocarcinoma. Carcinogenesis. 2007 Jul; 28(7):1430-6.
    View in: PubMed
    Score: 0.025
  16. Joint effect of mutagen sensitivity and insulin-like growth factors in predicting the risk of developing secondary primary tumors and tumor recurrence in patients with head and neck cancer. Clin Cancer Res. 2006 Dec 01; 12(23):7194-201.
    View in: PubMed
    Score: 0.025
  17. Never smokers and lung cancer risk: a case-control study of epidemiological factors. Int J Cancer. 2006 Apr 01; 118(7):1798-804.
    View in: PubMed
    Score: 0.024
  18. An epidemiologic study of early onset lung cancer. Lung Cancer. 2006 May; 52(2):129-34.
    View in: PubMed
    Score: 0.024
  19. Bladder cancer predisposition: a multigenic approach to DNA-repair and cell-cycle-control genes. Am J Hum Genet. 2006 Mar; 78(3):464-79.
    View in: PubMed
    Score: 0.023
  20. Dietary phytoestrogens and lung cancer risk. JAMA. 2005 Sep 28; 294(12):1493-504.
    View in: PubMed
    Score: 0.023
  21. Wood dust exposure and the association with lung cancer risk. Am J Ind Med. 2005 Apr; 47(4):349-57.
    View in: PubMed
    Score: 0.022
  22. Opposing effects of emphysema, hay fever, and select genetic variants on lung cancer risk. Am J Epidemiol. 2005 Mar 01; 161(5):412-22.
    View in: PubMed
    Score: 0.022
  23. Cell cycle checkpoints, DNA damage/repair, and lung cancer risk. Cancer Res. 2005 Jan 01; 65(1):349-57.
    View in: PubMed
    Score: 0.022
  24. Descriptive epidemiology and risk factors for head and neck cancer. Semin Oncol. 2004 Dec; 31(6):726-33.
    View in: PubMed
    Score: 0.022
  25. Serum levels of insulin growth factor (IGF-I) and IGF-binding protein predict risk of second primary tumors in patients with head and neck cancer. Clin Cancer Res. 2004 Jun 15; 10(12 Pt 1):3988-95.
    View in: PubMed
    Score: 0.021
  26. Hormone replacement therapy and lung cancer risk: a case-control analysis. Clin Cancer Res. 2004 Jan 01; 10(1 Pt 1):113-23.
    View in: PubMed
    Score: 0.020
  27. Risk for smoking-related cancer among relatives of lung cancer patients. Cancer Res. 2003 Dec 01; 63(23):8531-5.
    View in: PubMed
    Score: 0.020
  28. Association between low dietary folate intake and suboptimal cellular DNA repair capacity. Cancer Epidemiol Biomarkers Prev. 2003 Oct; 12(10):963-9.
    View in: PubMed
    Score: 0.020
  29. Dietary folate intake and lung cancer risk in former smokers: a case-control analysis. Cancer Epidemiol Biomarkers Prev. 2003 Oct; 12(10):980-6.
    View in: PubMed
    Score: 0.020
  30. Telomere dysfunction: a potential cancer predisposition factor. J Natl Cancer Inst. 2003 Aug 20; 95(16):1211-8.
    View in: PubMed
    Score: 0.020
  31. Genetic susceptibility to lung cancer: the role of DNA damage and repair. Cancer Epidemiol Biomarkers Prev. 2003 Aug; 12(8):689-98.
    View in: PubMed
    Score: 0.020
  32. XPA polymorphism associated with reduced lung cancer risk and a modulating effect on nucleotide excision repair capacity. Carcinogenesis. 2003 Mar; 24(3):505-9.
    View in: PubMed
    Score: 0.019
  33. Myeloperoxidase promoter region polymorphism and lung cancer risk. Methods Mol Med. 2003; 75:121-33.
    View in: PubMed
    Score: 0.019
  34. Assessment of insulin-like growth factors and mutagen sensitivity as predictors of lung cancer risk. Methods Mol Med. 2003; 75:279-87.
    View in: PubMed
    Score: 0.019
  35. Serum insulin-like growth factor (IGF) and IGF-binding protein levels and risk of lung cancer: a case-control study nested in the beta-Carotene and Retinol Efficacy Trial Cohort. Cancer Epidemiol Biomarkers Prev. 2002 Nov; 11(11):1413-8.
    View in: PubMed
    Score: 0.019
  36. p53 Genotypes and Haplotypes Associated With Lung Cancer Susceptibility and Ethnicity. J Natl Cancer Inst. 2002 May 01; 94(9):681-90.
    View in: PubMed
    Score: 0.018
  37. Dietary intake of isothiocyanates: evidence of a joint effect with glutathione S-transferase polymorphisms in lung cancer risk. Cancer Epidemiol Biomarkers Prev. 2000 Oct; 9(10):1017-20.
    View in: PubMed
    Score: 0.016
  38. Epidemiologic determinants of clinically relevant prostate cancer. Int J Cancer. 2000 May 20; 89(3):259-64.
    View in: PubMed
    Score: 0.016
  39. Joint effect of insulin-like growth factors and mutagen sensitivity in lung cancer risk. J Natl Cancer Inst. 2000 May 03; 92(9):737-43.
    View in: PubMed
    Score: 0.016
  40. Joint effect of insulin-like growth factors and mutagen sensitivity in lung cancer risk. Growth Horm IGF Res. 2000 Apr; 10 Suppl A:S26-7.
    View in: PubMed
    Score: 0.016
  41. Lung Cancer Risk in Never-Smokers of European Descent is Associated With Genetic Variation in the 5p15.33 TERT-CLPTM1Ll Region. J Thorac Oncol. 2019 08; 14(8):1360-1369.
    View in: PubMed
    Score: 0.015
  42. Cross-Cancer Pleiotropic Associations with Lung Cancer Risk in African Americans. Cancer Epidemiol Biomarkers Prev. 2019 04; 28(4):715-723.
    View in: PubMed
    Score: 0.014
  43. Is there a genetic basis for lung cancer susceptibility? Recent Results Cancer Res. 1999; 151:3-12.
    View in: PubMed
    Score: 0.014
  44. Genetic susceptibility to tobacco carcinogenesis. Cancer Invest. 1999; 17(8):645-59.
    View in: PubMed
    Score: 0.014
  45. Case-control study of diet and prostate cancer in China. Cancer Causes Control. 1998 Dec; 9(6):545-52.
    View in: PubMed
    Score: 0.014
  46. Mutagen sensitivity as a predictor of tumor recurrence in patients with cancer of the upper aerodigestive tract. J Natl Cancer Inst. 1998 Feb 04; 90(3):243-5.
    View in: PubMed
    Score: 0.013
  47. Deletion in poly(ADP-ribose)polymerase pseudogene and lung cancer risk. Carcinogenesis. 1998 Jan; 19(1):93-8.
    View in: PubMed
    Score: 0.013
  48. Correlates of mutagen sensitivity in patients with upper aerodigestive tract cancer. Cancer Epidemiol Biomarkers Prev. 1997 Sep; 6(9):687-92.
    View in: PubMed
    Score: 0.013
  49. The role of DNA repair capacity in susceptibility to lung cancer: a review. Cancer Metastasis Rev. 1997 Sep-Dec; 16(3-4):295-307.
    View in: PubMed
    Score: 0.013
  50. Identifying and recruiting healthy control subjects from a managed care organization: a methodology for molecular epidemiological case-control studies of cancer. Cancer Epidemiol Biomarkers Prev. 1997 Aug; 6(8):565-71.
    View in: PubMed
    Score: 0.013
  51. Case-control assessment of diet and lung cancer risk in African Americans and Mexican Americans. Nutr Cancer. 1997; 29(2):169-73.
    View in: PubMed
    Score: 0.012
  52. Reduced DNA repair capacity in lung cancer patients. Cancer Res. 1996 Sep 15; 56(18):4103-7.
    View in: PubMed
    Score: 0.012
  53. Benzo(a)pyrene diol epoxide-induced chromosomal aberrations and risk of lung cancer. Cancer Res. 1996 Sep 01; 56(17):3975-9.
    View in: PubMed
    Score: 0.012
  54. Higher lung cancer risk for younger African-Americans with the Pro/Pro p53 genotype. Carcinogenesis. 1995 Sep; 16(9):2205-8.
    View in: PubMed
    Score: 0.011
  55. Demographic, psychosocial, and genetic risk associated with smokeless tobacco use among Mexican heritage youth. BMC Med Genet. 2015 Jun 26; 16:43.
    View in: PubMed
    Score: 0.011
  56. Lower lung cancer rates in Jewish smokers in Israel and the USA. Int J Cancer. 2015 Nov 01; 137(9):2155-62.
    View in: PubMed
    Score: 0.011
  57. CHRNA5 risk variant predicts delayed smoking cessation and earlier lung cancer diagnosis--a meta-analysis. J Natl Cancer Inst. 2015 May; 107(5).
    View in: PubMed
    Score: 0.011
  58. Mutagen sensitivity as a biological marker of lung cancer risk in African Americans. Cancer Epidemiol Biomarkers Prev. 1995 Mar; 4(2):99-103.
    View in: PubMed
    Score: 0.011
  59. Risk factors and genetic susceptibility. Cancer Treat Res. 1995; 74:73-87.
    View in: PubMed
    Score: 0.011
  60. CYP2A6 reduced activity gene variants confer reduction in lung cancer risk in African American smokers--findings from two independent populations. Carcinogenesis. 2015 Jan; 36(1):99-103.
    View in: PubMed
    Score: 0.011
  61. Mutagen sensitivity as a risk factor for second malignant tumors following malignancies of the upper aerodigestive tract. J Natl Cancer Inst. 1994 Nov 16; 86(22):1681-4.
    View in: PubMed
    Score: 0.011
  62. A risk prediction model for smoking experimentation in Mexican American youth. Cancer Epidemiol Biomarkers Prev. 2014 Oct; 23(10):2165-74.
    View in: PubMed
    Score: 0.010
  63. Epidemiology and risk factors for head and neck cancer. Semin Oncol. 1994 Jun; 21(3):281-8.
    View in: PubMed
    Score: 0.010
  64. Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer. Nat Genet. 2014 Jul; 46(7):736-41.
    View in: PubMed
    Score: 0.010
  65. Inflammation-related genetic variations and survival in patients with advanced non-small cell lung cancer receiving first-line chemotherapy. Clin Pharmacol Ther. 2014 Sep; 96(3):360-369.
    View in: PubMed
    Score: 0.010
  66. Self-reported prior lung diseases as risk factors for non-small cell lung cancer in Mexican Americans. J Immigr Minor Health. 2013 Oct; 15(5):910-7.
    View in: PubMed
    Score: 0.010
  67. Cancer risk and early detection assessment. Semin Oncol Nurs. 1993 Aug; 9(3):188-97.
    View in: PubMed
    Score: 0.010
  68. Genetic susceptibility to cancer. Cancer. 1993 Aug 01; 72(3 Suppl):991-5.
    View in: PubMed
    Score: 0.010
  69. Bridging the clinical gaps: genetic, epigenetic and transcriptomic biomarkers for the early detection of lung cancer in the post-National Lung Screening Trial era. BMC Med. 2013 Jul 19; 11:168.
    View in: PubMed
    Score: 0.010
  70. Symptom clusters of pain, depressed mood, and fatigue in lung cancer: assessing the role of cytokine genes. Support Care Cancer. 2013 Nov; 21(11):3117-25.
    View in: PubMed
    Score: 0.010
  71. Mutagen sensitivity in upper aerodigestive tract cancer: a case-control analysis. Cancer Epidemiol Biomarkers Prev. 1993 Jul-Aug; 2(4):329-33.
    View in: PubMed
    Score: 0.010
  72. Genetic variation in the PNPLA3 gene and hepatocellular carcinoma in USA: risk and prognosis prediction. Mol Carcinog. 2013 Nov; 52 Suppl 1:E139-47.
    View in: PubMed
    Score: 0.010
  73. Heme-related gene expression signatures of meat intakes in lung cancer tissues. Mol Carcinog. 2014 Jul; 53(7):548-56.
    View in: PubMed
    Score: 0.010
  74. The associations of body image, anxiety, and smoking among Mexican-origin youth. J Adolesc Health. 2013 Aug; 53(2):209-14.
    View in: PubMed
    Score: 0.010
  75. Pilot study of CYP2B6 genetic variation to explore the contribution of nitrosamine activation to lung carcinogenesis. Int J Mol Sci. 2013 Apr 16; 14(4):8381-92.
    View in: PubMed
    Score: 0.010
  76. Investigating multiple candidate genes and nutrients in the folate metabolism pathway to detect genetic and nutritional risk factors for lung cancer. PLoS One. 2013; 8(1):e53475.
    View in: PubMed
    Score: 0.009
  77. Cigarette experimentation and the population attributable fraction for associated genetic and non-genetic risk factors. PLoS One. 2013; 8(1):e53868.
    View in: PubMed
    Score: 0.009
  78. Fine-mapping of the 5p15.33, 6p22.1-p21.31, and 15q25.1 regions identifies functional and histology-specific lung cancer susceptibility loci in African-Americans. Cancer Epidemiol Biomarkers Prev. 2013 Feb; 22(2):251-60.
    View in: PubMed
    Score: 0.009
  79. Genetic variations in interleukin-8 and interleukin-10 are associated with pain, depressed mood, and fatigue in lung cancer patients. J Pain Symptom Manage. 2013 Aug; 46(2):161-72.
    View in: PubMed
    Score: 0.009
  80. Association study of nicotinic acetylcholine receptor genes identifies a novel lung cancer susceptibility locus near CHRNA1 in African-Americans. Oncotarget. 2012 Nov; 3(11):1428-38.
    View in: PubMed
    Score: 0.009
  81. Genome-wide association study reveals novel genetic determinants of DNA repair capacity in lung cancer. Cancer Res. 2013 Jan 01; 73(1):256-64.
    View in: PubMed
    Score: 0.009
  82. Method for evaluating multiple mediators: mediating effects of smoking and COPD on the association between the CHRNA5-A3 variant and lung cancer risk. PLoS One. 2012; 7(10):e47705.
    View in: PubMed
    Score: 0.009
  83. Association between malignancies of the upper aerodigestive tract and uterine cervix. Head Neck. 1992 Sep-Oct; 14(5):347-51.
    View in: PubMed
    Score: 0.009
  84. Genetic variants in the PI3K/PTEN/AKT/mTOR pathway predict head and neck cancer patient second primary tumor/recurrence risk and response to retinoid chemoprevention. Clin Cancer Res. 2012 Jul 01; 18(13):3705-13.
    View in: PubMed
    Score: 0.009
  85. Body mass index and risk of lung cancer among never, former, and current smokers. J Natl Cancer Inst. 2012 May 16; 104(10):778-89.
    View in: PubMed
    Score: 0.009
  86. Increased risk of lung cancer in individuals with a family history of the disease: a pooled analysis from the International Lung Cancer Consortium. Eur J Cancer. 2012 Sep; 48(13):1957-68.
    View in: PubMed
    Score: 0.009
  87. Comparison of pathway analysis approaches using lung cancer GWAS data sets. PLoS One. 2012; 7(2):e31816.
    View in: PubMed
    Score: 0.009
  88. Genetic and environmental interactions as risks for aerodigestive cancers. Adv Exp Med Biol. 1992; 320:31-4.
    View in: PubMed
    Score: 0.009
  89. Roles of genetic variants in the PI3K and RAS/RAF pathways in susceptibility to endometrial cancer and clinical outcomes. J Cancer Res Clin Oncol. 2012 Mar; 138(3):377-85.
    View in: PubMed
    Score: 0.009
  90. Familial patterns of prostate cancer: a case-control analysis. J Urol. 1991 Nov; 146(5):1305-7.
    View in: PubMed
    Score: 0.009
  91. A case-control study of a sex-specific association between a 15q25 variant and lung cancer risk. Cancer Epidemiol Biomarkers Prev. 2011 Dec; 20(12):2603-9.
    View in: PubMed
    Score: 0.009
  92. p73 G4C14-to-A4T14 gene polymorphism and interaction with p53 exon 4 Arg72Pro on cancer susceptibility: a meta-analysis of the literature. Mutagenesis. 2012 May; 27(3):267-73.
    View in: PubMed
    Score: 0.009
  93. Dietary patterns affect lung cancer risk in never smokers. Nutr Cancer. 2011; 63(6):842-9.
    View in: PubMed
    Score: 0.009
  94. Novel genetic variants in the chromosome 5p15.33 region associate with lung cancer risk. Carcinogenesis. 2011 Oct; 32(10):1493-9.
    View in: PubMed
    Score: 0.009
  95. Relationship between CYP2A6 and CHRNA5-CHRNA3-CHRNB4 variation and smoking behaviors and lung cancer risk. J Natl Cancer Inst. 2011 Sep 07; 103(17):1342-6.
    View in: PubMed
    Score: 0.008
  96. Association of smoking with tumor size at diagnosis in non-small cell lung cancer. Lung Cancer. 2011 Dec; 74(3):378-83.
    View in: PubMed
    Score: 0.008
  97. Global assessment of genetic variation influencing response to retinoid chemoprevention in head and neck cancer patients. Cancer Prev Res (Phila). 2011 Feb; 4(2):185-93.
    View in: PubMed
    Score: 0.008
  98. Risk profiles of women with cervical neoplasia. J Cancer Educ. 1991; 6(4):241-6.
    View in: PubMed
    Score: 0.008
  99. Admixture mapping of lung cancer in 1812 African-Americans. Carcinogenesis. 2011 Mar; 32(3):312-7.
    View in: PubMed
    Score: 0.008
  100. Salivary gland cancer. A case-control investigation of risk factors. Arch Otolaryngol Head Neck Surg. 1990 Oct; 116(10):1163-6.
    View in: PubMed
    Score: 0.008
  101. Assessing environmental and occupational risk factors for lung cancer in Mexican-Americans. Cancer Causes Control. 2010 Dec; 21(12):2157-64.
    View in: PubMed
    Score: 0.008
  102. Rapid method for determination of DNA repair capacity in human peripheral blood lymphocytes amongst smokers. BMC Cancer. 2010 Aug 18; 10:439.
    View in: PubMed
    Score: 0.008
  103. Comparison of discriminatory power and accuracy of three lung cancer risk models. Br J Cancer. 2010 Jul 27; 103(3):423-9.
    View in: PubMed
    Score: 0.008
  104. Replication of lung cancer susceptibility loci at chromosomes 15q25, 5p15, and 6p21: a pooled analysis from the International Lung Cancer Consortium. J Natl Cancer Inst. 2010 Jul 07; 102(13):959-71.
    View in: PubMed
    Score: 0.008
  105. Salivary gland cancer and risk of subsequent skin cancer. Head Neck. 1990 May-Jun; 12(3):254-6.
    View in: PubMed
    Score: 0.008
  106. Early cancer detection: update for primary-care physicians. Tex Med. 1990 Apr; 86(4):44-7.
    View in: PubMed
    Score: 0.008
  107. Reduced DNA repair capacity for removing tobacco carcinogen-induced DNA adducts contributes to risk of head and neck cancer but not tumor characteristics. Clin Cancer Res. 2010 Jan 15; 16(2):764-74.
    View in: PubMed
    Score: 0.008
  108. Cigarette smoking patterns in patients after treatment of upper aerodigestive tract cancers. J Cancer Educ. 1990; 5(2):109-13.
    View in: PubMed
    Score: 0.008
  109. Cigarette smoking patterns of cancer patients. Prog Clin Biol Res. 1990; 339:73-82.
    View in: PubMed
    Score: 0.008
  110. Exposure to smoking imagery in the movies and experimenting with cigarettes among Mexican heritage youth. Cancer Epidemiol Biomarkers Prev. 2009 Dec; 18(12):3435-43.
    View in: PubMed
    Score: 0.008
  111. Cognitive susceptibility to smoking: Two paths to experimenting among Mexican origin youth. Cancer Epidemiol Biomarkers Prev. 2009 Dec; 18(12):3459-67.
    View in: PubMed
    Score: 0.008
  112. A genome-wide association study of lung cancer identifies a region of chromosome 5p15 associated with risk for adenocarcinoma. Am J Hum Genet. 2009 11; 85(5):679-91.
    View in: PubMed
    Score: 0.008
  113. Novel susceptibility loci for second primary tumors/recurrence in head and neck cancer patients: large-scale evaluation of genetic variants. Cancer Prev Res (Phila). 2009 Jul; 2(7):617-24.
    View in: PubMed
    Score: 0.007
  114. The implementation and applications of a cancer patient risk evaluation questionnaire. Prog Clin Biol Res. 1989; 293:263-70.
    View in: PubMed
    Score: 0.007
  115. Genetic variations in cell-cycle pathway and the risk of oral premalignant lesions. Cancer. 2008 Nov 01; 113(9):2488-95.
    View in: PubMed
    Score: 0.007
  116. Effect of different types of smoking and synergism with hepatitis C virus on risk of hepatocellular carcinoma in American men and women: case-control study. Int J Cancer. 2008 Oct 15; 123(8):1883-91.
    View in: PubMed
    Score: 0.007
  117. Dietary alpha-, beta-, gamma- and delta-tocopherols in lung cancer risk. Int J Cancer. 2008 Sep 01; 123(5):1173-80.
    View in: PubMed
    Score: 0.007
  118. Mitochondrial DNA content: its genetic heritability and association with renal cell carcinoma. J Natl Cancer Inst. 2008 Aug 06; 100(15):1104-12.
    View in: PubMed
    Score: 0.007
  119. Trends in prevalence of prognostic factors and survival in lung cancer patients from 1985 to 2004 at a tertiary care center. Cancer Detect Prev. 2008; 32(2):101-8.
    View in: PubMed
    Score: 0.007
  120. Genetic polymorphisms in double-strand break DNA repair genes associated with risk of oral premalignant lesions. Eur J Cancer. 2008 Jul; 44(11):1603-11.
    View in: PubMed
    Score: 0.007
  121. Chromosome instability and risk of squamous cell carcinomas of head and neck. Cancer Res. 2008 Jun 01; 68(11):4479-85.
    View in: PubMed
    Score: 0.007
  122. DNA repair capacity and lung cancer risk in never smokers. Cancer Epidemiol Biomarkers Prev. 2008 Jun; 17(6):1322-8.
    View in: PubMed
    Score: 0.007
  123. Incidence of salivary gland cancer in the United States relative to ultraviolet radiation exposure. Head Neck Surg. 1988 May-Jun; 10(5):305-8.
    View in: PubMed
    Score: 0.007
  124. Cytokinesis-blocked micronucleus cytome assay biomarkers identify lung cancer cases amongst smokers. Cancer Epidemiol Biomarkers Prev. 2008 May; 17(5):1111-9.
    View in: PubMed
    Score: 0.007
  125. Dietary magnesium and DNA repair capacity as risk factors for lung cancer. Carcinogenesis. 2008 May; 29(5):949-56.
    View in: PubMed
    Score: 0.007
  126. Dietary boron and hormone replacement therapy as risk factors for lung cancer in women. Am J Epidemiol. 2008 May 01; 167(9):1070-80.
    View in: PubMed
    Score: 0.007
  127. Squamous cell carcinoma of the upper aerodigestive tract. A case comparison analysis. Cancer. 1988 Jan 01; 61(1):203-8.
    View in: PubMed
    Score: 0.007
  128. Joint effects of dietary trace metals and DNA repair capacity in lung cancer risk. Cancer Epidemiol Biomarkers Prev. 2007 Dec; 16(12):2756-62.
    View in: PubMed
    Score: 0.007
  129. ATM sequence variants associate with susceptibility to non-small cell lung cancer. Int J Cancer. 2007 Nov 15; 121(10):2254-9.
    View in: PubMed
    Score: 0.007
  130. Seizure 6-like (SEZ6L) gene and risk for lung cancer. Cancer Res. 2007 Sep 01; 67(17):8406-11.
    View in: PubMed
    Score: 0.007
  131. Genetic polymorphisms in DNA base-excision repair genes ADPRT, XRCC1, and APE1 and the risk of squamous cell carcinoma of the head and neck. Cancer. 2007 Aug 15; 110(4):867-75.
    View in: PubMed
    Score: 0.006
  132. Potentially functional single nucleotide polymorphisms in the core nucleotide excision repair genes and risk of squamous cell carcinoma of the head and neck. Cancer Epidemiol Biomarkers Prev. 2007 Aug; 16(8):1633-8.
    View in: PubMed
    Score: 0.006
  133. Deficient G2-M and S checkpoints are associated with increased lung cancer risk: a case-control analysis. Cancer Epidemiol Biomarkers Prev. 2007 Jul; 16(7):1517-22.
    View in: PubMed
    Score: 0.006
  134. Polymorphisms of cytosolic serine hydroxymethyltransferase and risk of lung cancer: a case-control analysis. Lung Cancer. 2007 Aug; 57(2):143-51.
    View in: PubMed
    Score: 0.006
  135. Association of genetic variants of O6-methylguanine-DNA methyltransferase with risk of lung cancer in non-Hispanic Whites. Cancer Epidemiol Biomarkers Prev. 2006 Dec; 15(12):2364-9.
    View in: PubMed
    Score: 0.006
  136. Meta- and pooled analysis of GSTT1 and lung cancer: a HuGE-GSEC review. Am J Epidemiol. 2006 Dec 01; 164(11):1027-42.
    View in: PubMed
    Score: 0.006
  137. Polymorphisms of FAS and FAS ligand genes involved in the death pathway and risk and progression of squamous cell carcinoma of the head and neck. Clin Cancer Res. 2006 Sep 15; 12(18):5596-602.
    View in: PubMed
    Score: 0.006
  138. Polymorphisms of STK15 (Aurora-A) gene and lung cancer risk in Caucasians. Carcinogenesis. 2007 Feb; 28(2):350-5.
    View in: PubMed
    Score: 0.006
  139. Bladder cancer risk as modified by family history and smoking. Cancer. 2006 Aug 15; 107(4):705-11.
    View in: PubMed
    Score: 0.006
  140. Evaluation of glutathione S-transferase polymorphisms and mutagen sensitivity as risk factors for the development of second primary tumors in patients previously diagnosed with early-stage head and neck cancer. Cancer. 2006 Jun 15; 106(12):2636-44.
    View in: PubMed
    Score: 0.006
  141. Cyclin D1 gene polymorphism as a risk factor for oral premalignant lesions. Carcinogenesis. 2006 Oct; 27(10):2034-7.
    View in: PubMed
    Score: 0.006
  142. In vitro sensitivity to ultraviolet B light and skin cancer risk: a case-control analysis. J Natl Cancer Inst. 2005 Dec 21; 97(24):1822-31.
    View in: PubMed
    Score: 0.006
  143. Polymorphisms of methionine synthase and methionine synthase reductase and risk of lung cancer: a case-control analysis. Pharmacogenet Genomics. 2005 Aug; 15(8):547-55.
    View in: PubMed
    Score: 0.006
  144. Polymorphisms and haplotypes of serine hydroxymethyltransferase and risk of squamous cell carcinoma of the head and neck: a case-control analysis. Pharmacogenet Genomics. 2005 Aug; 15(8):557-64.
    View in: PubMed
    Score: 0.006
  145. Sex differences in risk of lung cancer associated with methylene-tetrahydrofolate reductase polymorphisms. Cancer Epidemiol Biomarkers Prev. 2005 Jun; 14(6):1477-84.
    View in: PubMed
    Score: 0.006
  146. Methylenetetrahydrofolate reductase polymorphisms and risk of squamous cell carcinoma of the head and neck: a case-control analysis. Int J Cancer. 2005 May 20; 115(1):131-6.
    View in: PubMed
    Score: 0.006
  147. Genetic polymorphisms of p21 are associated with risk of squamous cell carcinoma of the head and neck. Carcinogenesis. 2005 Sep; 26(9):1596-602.
    View in: PubMed
    Score: 0.006
  148. Inflammatory gene polymorphisms influence risk of postoperative morbidity after lung resection. Ann Thorac Surg. 2005 May; 79(5):1704-10.
    View in: PubMed
    Score: 0.006
  149. Polymorphisms of methionine synthase and methionine synthase reductase and risk of squamous cell carcinoma of the head and neck: a case-control analysis. Cancer Epidemiol Biomarkers Prev. 2005 May; 14(5):1188-93.
    View in: PubMed
    Score: 0.006
  150. The biology of tobacco and nicotine: bench to bedside. Cancer Epidemiol Biomarkers Prev. 2005 Apr; 14(4):764-7.
    View in: PubMed
    Score: 0.006
  151. Chromosomal instability in peripheral blood lymphocytes and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev. 2005 Mar; 14(3):748-52.
    View in: PubMed
    Score: 0.005
  152. Relationship between plasma carotenoids and prostate cancer. Nutr Cancer. 2005; 53(2):127-34.
    View in: PubMed
    Score: 0.005
  153. Case-control analysis of dietary folate and risk of bladder cancer. Nutr Cancer. 2005; 53(2):144-51.
    View in: PubMed
    Score: 0.005
  154. Case-control analysis of thymidylate synthase polymorphisms and risk of lung cancer. Carcinogenesis. 2005 Mar; 26(3):649-56.
    View in: PubMed
    Score: 0.005
  155. Dietary carotenoids and genetic instability modify bladder cancer risk. J Nutr. 2004 Dec; 134(12):3362-9.
    View in: PubMed
    Score: 0.005
  156. Thymidylate synthase 5'- and 3'-untranslated region polymorphisms associated with risk and progression of squamous cell carcinoma of the head and neck. Clin Cancer Res. 2004 Dec 01; 10(23):7903-10.
    View in: PubMed
    Score: 0.005
  157. p73 G4C14-to-A4T14 polymorphism and risk of lung cancer. Cancer Res. 2004 Oct 01; 64(19):6863-6.
    View in: PubMed
    Score: 0.005
  158. Androgen receptor polymorphisms and risk of biochemical failure among prostatectomy patients. Prostate. 2004 Sep 01; 60(4):343-51.
    View in: PubMed
    Score: 0.005
  159. Association of a p73 exon 2 G4C14-to-A4T14 polymorphism with risk of squamous cell carcinoma of the head and neck. Carcinogenesis. 2004 Oct; 25(10):1911-6.
    View in: PubMed
    Score: 0.005
  160. No Association between hOGG1 Ser326Cys polymorphism and risk of squamous cell carcinoma of the head and neck. Cancer Epidemiol Biomarkers Prev. 2004 Jun; 13(6):1081-3.
    View in: PubMed
    Score: 0.005
  161. Methyl-CpG-binding domain 2: a protective role in bladder carcinoma. Cancer. 2004 May 01; 100(9):1853-8.
    View in: PubMed
    Score: 0.005
  162. Polymorphisms of folate metabolic genes and susceptibility to bladder cancer: a case-control study. Carcinogenesis. 2004 Sep; 25(9):1639-47.
    View in: PubMed
    Score: 0.005
  163. An evolutionary perspective on single-nucleotide polymorphism screening in molecular cancer epidemiology. Cancer Res. 2004 Mar 15; 64(6):2251-7.
    View in: PubMed
    Score: 0.005
  164. Training future pharmacists at a minority educational institution: evaluation of the Rx for change tobacco cessation training program. Cancer Epidemiol Biomarkers Prev. 2004 Mar; 13(3):477-81.
    View in: PubMed
    Score: 0.005
  165. p53 codon 72 Arg homozygotes are associated with an increased risk of cutaneous melanoma. J Invest Dermatol. 2003 Dec; 121(6):1510-4.
    View in: PubMed
    Score: 0.005
  166. Smoking, DNA repair capacity and risk of nonsmall cell lung cancer. Int J Cancer. 2003 Oct 20; 107(1):84-8.
    View in: PubMed
    Score: 0.005
  167. Fas A670G polymorphism, apoptotic capacity in lymphocyte cultures, and risk of lung cancer. Lung Cancer. 2003 Oct; 42(1):1-8.
    View in: PubMed
    Score: 0.005
  168. Human papillomavirus type 16 infection and squamous cell carcinoma of the head and neck in never-smokers: a matched pair analysis. Clin Cancer Res. 2003 Jul; 9(7):2620-6.
    View in: PubMed
    Score: 0.005
  169. Association between glutathione S-transferase p1 polymorphisms and lung cancer risk in Caucasians: a case-control study. Lung Cancer. 2003 Apr; 40(1):25-32.
    View in: PubMed
    Score: 0.005
  170. Death receptor 4 and bladder cancer risk. Cancer Res. 2003 Mar 15; 63(6):1157-9.
    View in: PubMed
    Score: 0.005
  171. Overexpression of hMTH in peripheral lymphocytes and risk of prostate cancer: a case-control analysis. Mol Carcinog. 2003 Mar; 36(3):123-9.
    View in: PubMed
    Score: 0.005
  172. Repair of UV light-induced DNA damage and risk of cutaneous malignant melanoma. J Natl Cancer Inst. 2003 Feb 19; 95(4):308-15.
    View in: PubMed
    Score: 0.005
  173. Plasma levels of insulin-like growth factor-1 and binding protein-3, and their association with bladder cancer risk. J Urol. 2003 Feb; 169(2):714-7.
    View in: PubMed
    Score: 0.005
  174. DNA repair gene XRCC3 241Met variant is not associated with risk of cutaneous malignant melanoma. Cancer Epidemiol Biomarkers Prev. 2002 Oct; 11(10 Pt 1):1142-3.
    View in: PubMed
    Score: 0.005
  175. A novel polymorphism in human cytosine DNA-methyltransferase-3B promoter is associated with an increased risk of lung cancer. Cancer Res. 2002 Sep 01; 62(17):4992-5.
    View in: PubMed
    Score: 0.005
  176. XPD/ERCC2 EXON 8 Polymorphisms: rarity and lack of significance in risk of squamous cell carcinoma of the head and neck. Oral Oncol. 2002 Jul; 38(5):475-7.
    View in: PubMed
    Score: 0.005
  177. A variant of the DNA repair gene XRCC3 and risk of squamous cell carcinoma of the head and neck: a case-control analysis. Int J Cancer. 2002 Jun 20; 99(6):869-72.
    View in: PubMed
    Score: 0.005
  178. Polymorphism of DNA ligase I and risk of lung cancer--a case-control analysis. Lung Cancer. 2002 Jun; 36(3):243-7.
    View in: PubMed
    Score: 0.005
  179. Sulfotransferase (SULT) 1A1 polymorphism as a predisposition factor for lung cancer: a case-control analysis. Lung Cancer. 2002 Feb; 35(2):137-42.
    View in: PubMed
    Score: 0.004
  180. Microsomal epoxide hydrolase polymorphisms and lung cancer risk in non-Hispanic whites. Mol Carcinog. 2002 Feb; 33(2):99-104.
    View in: PubMed
    Score: 0.004
  181. Expression of nucleotide excision repair genes and the risk for squamous cell carcinoma of the head and neck. Cancer. 2002 Jan 15; 94(2):393-7.
    View in: PubMed
    Score: 0.004
  182. Polymorphisms of 5,10-methylenetetrahydrofolate reductase and risk of gastric cancer in a Chinese population: a case-control study. Int J Cancer. 2001 Sep 20; 95(5):332-6.
    View in: PubMed
    Score: 0.004
  183. Molecular epidemiologic studies within the Selenium and Vitamin E Cancer Prevention Trial (SELECT). Cancer Causes Control. 2001 Sep; 12(7):627-33.
    View in: PubMed
    Score: 0.004
  184. In vitro BPDE-induced DNA adducts in peripheral lymphocytes as a risk factor for squamous cell carcinoma of the head and neck. Int J Cancer. 2001 Aug 01; 93(3):436-40.
    View in: PubMed
    Score: 0.004
  185. Cyclin D1 polymorphism and risk for squamous cell carcinoma of the head and neck: a case-control study. Carcinogenesis. 2001 Aug; 22(8):1195-9.
    View in: PubMed
    Score: 0.004
  186. The development of breast carcinoma in women with thyroid carcinoma. Cancer. 2001 Jul 15; 92(2):225-31.
    View in: PubMed
    Score: 0.004
  187. Polymorphisms of methylene-tetrahydrofolate reductase and risk of lung cancer: a case-control study. Cancer Epidemiol Biomarkers Prev. 2001 Apr; 10(4):397-401.
    View in: PubMed
    Score: 0.004
  188. Alcohol dehydrogenase 3 genotype is not associated with risk of squamous cell carcinoma of the oral cavity and pharynx. Cancer Epidemiol Biomarkers Prev. 2001 Mar; 10(3):273-5.
    View in: PubMed
    Score: 0.004
  189. XPD/ERCC2 polymorphisms and risk of head and neck cancer: a case-control analysis. Carcinogenesis. 2000 Dec; 21(12):2219-23.
    View in: PubMed
    Score: 0.004
  190. Polymorphisms of the DNA repair gene XRCC1 and risk of gastric cancer in a Chinese population. Int J Cancer. 2000 Nov 15; 88(4):601-6.
    View in: PubMed
    Score: 0.004
  191. Environmental tobacco smoking, mutagen sensitivity, and head and neck squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev. 2000 Oct; 9(10):1043-9.
    View in: PubMed
    Score: 0.004
  192. Reduced expression levels of nucleotide excision repair genes in lung cancer: a case-control analysis. Carcinogenesis. 2000 Aug; 21(8):1527-30.
    View in: PubMed
    Score: 0.004
  193. Genetic variants of myeloperoxidase and lung cancer risk. Carcinogenesis. 2000 Jun; 21(6):1163-6.
    View in: PubMed
    Score: 0.004
  194. Adenocarcinoma of the lung in young patients: the M. D. Anderson experience. Cancer. 2000 Apr 15; 88(8):1837-41.
    View in: PubMed
    Score: 0.004
  195. Analysis of aromatic DNA adducts and 7,8-dihydro-8-oxo- 2'-deoxyguanosine in lymphocyte DNA from a case-control study of lung cancer involving minority populations. Mol Carcinog. 2000 Jan; 27(1):34-46.
    View in: PubMed
    Score: 0.004
  196. Marijuana use and increased risk of squamous cell carcinoma of the head and neck. Cancer Epidemiol Biomarkers Prev. 1999 Dec; 8(12):1071-8.
    View in: PubMed
    Score: 0.004
  197. Family history of cancer, mutagen sensitivity, and increased risk of head and neck cancer. Cancer Lett. 1999 Nov 01; 146(1):93-101.
    View in: PubMed
    Score: 0.004
  198. Glutathione-S-transferase polymorphisms and risk of squamous-cell carcinoma of the head and neck. Int J Cancer. 1999 Jun 21; 84(3):220-4.
    View in: PubMed
    Score: 0.004
  199. Plasma levels of insulin-like growth factor-I and lung cancer risk: a case-control analysis. J Natl Cancer Inst. 1999 Jan 20; 91(2):151-6.
    View in: PubMed
    Score: 0.004
  200. Phytoestrogen intake and prostate cancer: a case-control study using a new database. Nutr Cancer. 1999; 33(1):20-5.
    View in: PubMed
    Score: 0.004
  201. Reduced DNA repair capacity in head and neck cancer patients. Cancer Epidemiol Biomarkers Prev. 1998 Jun; 7(6):465-8.
    View in: PubMed
    Score: 0.003
  202. Reduced expression of hMLH1 and hGTBP/hMSH6: a risk factor for head and neck cancer. Cancer Epidemiol Biomarkers Prev. 1998 Apr; 7(4):309-14.
    View in: PubMed
    Score: 0.003
  203. Evaluation of sister chromatid exchange and chromosome breaks in a cohort of untreated Hodgkin's disease patients. Cancer Epidemiol Biomarkers Prev. 1997 Apr; 6(4):291-3.
    View in: PubMed
    Score: 0.003
  204. Lung cancer in Mexican-Americans and African-Americans is associated with the wild-type genotype of the NAD(P)H: quinone oxidoreductase polymorphism. Cancer Epidemiol Biomarkers Prev. 1997 Feb; 6(2):87-92.
    View in: PubMed
    Score: 0.003
  205. Lung carcinoma in former smokers. Cancer. 1996 Sep 01; 78(5):1004-10.
    View in: PubMed
    Score: 0.003
  206. In vitro induction of benzo(a)pyrene diol epoxide-DNA adducts in peripheral lymphocytes as a susceptibility marker for human lung cancer. Cancer Res. 1996 Aug 15; 56(16):3638-41.
    View in: PubMed
    Score: 0.003
  207. Correlation between selected environmental exposures and karyotype in acute myelocytic leukemia. Cancer Epidemiol Biomarkers Prev. 1996 Aug; 5(8):639-44.
    View in: PubMed
    Score: 0.003
  208. A statistical analysis of the reliability and classification error in application of the mutagen sensitivity assay. Cancer Epidemiol Biomarkers Prev. 1996 Mar; 5(3):191-7.
    View in: PubMed
    Score: 0.003
  209. Glutathione s-transferase genotypes as risk factors for head and neck cancer. Am J Surg. 1995 Nov; 170(5):499-501.
    View in: PubMed
    Score: 0.003
  210. Genetic susceptibility to lung cancer as determined by lymphocytic chromosome analysis. Cancer Epidemiol Biomarkers Prev. 1995 Oct-Nov; 4(7):743-9.
    View in: PubMed
    Score: 0.003
  211. Excess leukemia and multiple myeloma in a mining county in northeast Texas. Tex Med. 1994 Feb; 90(2):55-9.
    View in: PubMed
    Score: 0.003
  212. Association between family history of cancer and mutagen sensitivity in upper aerodigestive tract cancer patients. Cancer Epidemiol Biomarkers Prev. 1993 Mar-Apr; 2(2):103-6.
    View in: PubMed
    Score: 0.002
  213. Low incidence of familial breast cancer among Hispanic women. Cancer Causes Control. 1992 Jul; 3(4):377-82.
    View in: PubMed
    Score: 0.002
  214. Mutagen sensitivity: a biological marker of cancer susceptibility. Cancer Epidemiol Biomarkers Prev. 1991 Nov-Dec; 1(1):83-9.
    View in: PubMed
    Score: 0.002
  215. Mutagen sensitivity in patients with head and neck cancers: a biologic marker for risk of multiple primary malignancies. J Natl Cancer Inst. 1990 Nov 21; 82(22):1773-5.
    View in: PubMed
    Score: 0.002
  216. A case-control study of prostate cancer. Am J Epidemiol. 1989 Aug; 130(2):395-8.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.